Antinuclear Antibodies in Healthy People and Non-rheumatic Diseases - Diagnostic and Clinical Implications

Overview

Journal Reumatologia

Publisher Termedia

Specialty Rheumatology

Date 2018 Sep 22

PMID 30237629

Citations 43

Authors

Bogna Grygiel-Gorniak

Natalia Rogacka

Mariusz Puszczewicz

Affiliations

Soon will be listed here.

Abstract

The presence of antinuclear antibodies (ANA) is mainly associated with connective tissue diseases (CTD). In addition, their presence is found in healthy people. These antibodies are more common in women and the elderly. Some drugs and xenobiotics are also important for the development of autoimmunity and ANA synthesis. Moreover, the deficiency of vitamin D in the body of patients correlates with occurrence of these antibodies. Unlike the healthy group, a positive ANA count was observed in patients with atopic dermatitis (AD) and in people with immune disorders. Antinuclear antibodies in low counts are also found in the course of chronic bacterial or viral infection and in patients with hematological malignancies. Also the possibility of false positive results, which may be caused by the choice of method used to determine antibodies, should be borne in mind. Taking into account all these factors, it is concluded that the ANA result itself has no diagnostic value.

Citing Articles

Exploring the predictive power of antinuclear antibodies and Rheumatoid factor correlations in anticipating therapeutic outcomes for female patients with coexisting Sjögren's syndrome and Rheumatoid arthritis.

Krishnan Pandarathodiyil A, Shree K H, Ramani P, Sivapathasundharam B, Ramadoss R J Oral Biol Craniofac Res. 2025; 15(2):288-296.

PMID: 40027855 PMC: 11869106. DOI: 10.1016/j.jobcr.2025.01.012.

Autoantibodies in COVID-19: implications for disease severity and clinical outcomes.

Galipeau Y, Cooper C, Langlois M Front Immunol. 2025; 15():1509289.

PMID: 39835117 PMC: 11743527. DOI: 10.3389/fimmu.2024.1509289.

The Discovery of New Antibody in Autoimmune Disease Using a Novel Approach of Coombs Test Based on Flow Cytometry Method.

Ullah A, Ding X, Qi X, Liu H J Clin Lab Anal. 2025; 39(3):e25148.

PMID: 39829383 PMC: 11821728. DOI: 10.1002/jcla.25148.

Characterization of Dendritic Cells and Myeloid-Derived Suppressor Cells Expressing Major Histocompatibility Complex Class II in Secondary Lymphoid Organs in Systemic Lupus Erythematosus-Prone Mice.

Uribe F, Gonzalez-Martinez F, Echeverria-Araya S, Sepulveda-Pontigo A, Chavez-Villacreses K, Diaz-Bozo A Int J Mol Sci. 2025; 25(24.

PMID: 39769367 PMC: 11676837. DOI: 10.3390/ijms252413604.

Internal Ophthalmoplegic Migraine During Pregnancy: A Clinical Case.

Castillo-Guerrero B, Londono-Juliao G, Pianetta Y, Gutierrez-Rey M, Zuniga B, Pestana G Neurol Int. 2024; 16(6):1779-1787.

PMID: 39728754 PMC: 11677585. DOI: 10.3390/neurolint16060128.

References

Sacks G, Studena K, Sargent K, Redman C . Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol. 1998; 179(1):80-6. DOI: 10.1016/s0002-9378(98)70254-6. View

Crow M, Kirou K . Interferon-alpha in systemic lupus erythematosus. Curr Opin Rheumatol. 2004; 16(5):541-7. DOI: 10.1097/01.bor.0000135453.70424.1b. View

Meroni P, Schur P . ANA screening: an old test with new recommendations. Ann Rheum Dis. 2010; 69(8):1420-2. DOI: 10.1136/ard.2009.127100. View

Bernhoft R . Mercury toxicity and treatment: a review of the literature. J Environ Public Health. 2012; 2012:460508. PMC: 3253456. DOI: 10.1155/2012/460508. View

Fang J, Stingley R, Beland F, Harrouk W, Lumpkins D, Howard P . Occurrence, efficacy, metabolism, and toxicity of triclosan. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2010; 28(3):147-71. DOI: 10.1080/10590501.2010.504978. View

Agmon-Levin N, Damoiseaux J, Kallenberg C, Sack U, Witte T, Herold M . International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. Ann Rheum Dis. 2013; 73(1):17-23. DOI: 10.1136/annrheumdis-2013-203863. View

Singh D, Ohguro N, Kikuchi T, Sueno T, Reddy V, YUGE K . Lens epithelium-derived growth factor: effects on growth and survival of lens epithelial cells, keratinocytes, and fibroblasts. Biochem Biophys Res Commun. 2000; 267(1):373-81. DOI: 10.1006/bbrc.1999.1979. View

Quintero O, Amador-Patarroyo M, Montoya-Ortiz G, Rojas-Villarraga A, Anaya J . Autoimmune disease and gender: plausible mechanisms for the female predominance of autoimmunity. J Autoimmun. 2011; 38(2-3):J109-19. DOI: 10.1016/j.jaut.2011.10.003. View

Ochs R, Muro Y, Si Y, Ge H, Chan E, Tan E . Autoantibodies to DFS 70 kd/transcription coactivator p75 in atopic dermatitis and other conditions. J Allergy Clin Immunol. 2000; 105(6 Pt 1):1211-20. DOI: 10.1067/mai.2000.107039. View

10.

Ritterhouse L, Crowe S, Niewold T, Kamen D, Macwana S, Roberts V . Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus. Ann Rheum Dis. 2011; 70(9):1569-74. PMC: 3149865. DOI: 10.1136/ard.2010.148494. View

11.

Davidson A, Diamond B . Autoimmune diseases. N Engl J Med. 2001; 345(5):340-50. DOI: 10.1056/NEJM200108023450506. View

12.

Wandstrat A, Carr-Johnson F, Branch V, Gray H, Fairhurst A, Reimold A . Autoantibody profiling to identify individuals at risk for systemic lupus erythematosus. J Autoimmun. 2006; 27(3):153-60. DOI: 10.1016/j.jaut.2006.09.001. View

13.

Marin G, Cardiel M, Cornejo H, Viveros M . Prevalence of antinuclear antibodies in 3 groups of healthy individuals: blood donors, hospital personnel, and relatives of patients with autoimmune diseases. J Clin Rheumatol. 2009; 15(7):325-9. DOI: 10.1097/RHU.0b013e3181bb971b. View

14.

Cooper G, Martin S, Longnecker M, Sandler D, Germolec D . Associations between plasma DDE levels and immunologic measures in African-American farmers in North Carolina. Environ Health Perspect. 2004; 112(10):1080-4. PMC: 1247381. DOI: 10.1289/ehp.6892. View

15.

Hayashi N, Koshiba M, Nishimura K, Sugiyama D, Nakamura T, Morinobu S . Prevalence of disease-specific antinuclear antibodies in general population: estimates from annual physical examinations of residents of a small town over a 5-year period. Mod Rheumatol. 2008; 18(2):153-60. DOI: 10.1007/s10165-008-0028-1. View

16.

Pfau J, Sentissi J, Weller G, Putnam E . Assessment of autoimmune responses associated with asbestos exposure in Libby, Montana, USA. Environ Health Perspect. 2005; 113(1):25-30. PMC: 1253705. DOI: 10.1289/ehp.7431. View

17.

Nilsson B, Skogh T, Ernerudh J, Johansson B, Lofgren S, Wikby A . Antinuclear antibodies in the oldest-old women and men. J Autoimmun. 2006; 27(4):281-8. DOI: 10.1016/j.jaut.2006.10.002. View

18.

Li Q, Karp D, Quan J, Branch V, Zhou J, Lian Y . Risk factors for ANA positivity in healthy persons. Arthritis Res Ther. 2011; 13(2):R38. PMC: 3132017. DOI: 10.1186/ar3271. View

19.

Tan E . Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol. 1989; 44:93-151. DOI: 10.1016/s0065-2776(08)60641-0. View

20.

Pisetsky D, Lipsky P . Role of Antinuclear Antibody Determinations in Classification Criteria for Systemic Lupus Erythematosus: Comment on the Article by Leuchten et al. Arthritis Care Res (Hoboken). 2018; 71(5):696. DOI: 10.1002/acr.23559. View